409 related articles for article (PubMed ID: 34601126)
1. Filamin-C variant-associated cardiomyopathy: A pooled analysis of individual patient data to evaluate the clinical profile and risk of sudden cardiac death.
Celeghin R; Cipriani A; Bariani R; Bueno Marinas M; Cason M; Bevilacqua M; De Gaspari M; Rizzo S; Rigato I; Da Pozzo S; Zorzi A; Perazzolo Marra M; Thiene G; Iliceto S; Basso C; Corrado D; Pilichou K; Bauce B
Heart Rhythm; 2022 Feb; 19(2):235-243. PubMed ID: 34601126
[TBL] [Abstract][Full Text] [Related]
2. Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype.
Hall CL; Akhtar MM; Sabater-Molina M; Futema M; Asimaki A; Protonotarios A; Dalageorgou C; Pittman AM; Suarez MP; Aguilera B; Molina P; Zorio E; Hernández JP; Pastor F; Gimeno JR; Syrris P; McKenna WJ
Int J Cardiol; 2020 May; 307():101-108. PubMed ID: 31627847
[TBL] [Abstract][Full Text] [Related]
3. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies.
Ortiz-Genga MF; Cuenca S; Dal Ferro M; Zorio E; Salgado-Aranda R; Climent V; Padrón-Barthe L; Duro-Aguado I; Jiménez-Jáimez J; Hidalgo-Olivares VM; García-Campo E; Lanzillo C; Suárez-Mier MP; Yonath H; Marcos-Alonso S; Ochoa JP; Santomé JL; García-Giustiniani D; Rodríguez-Garrido JL; Domínguez F; Merlo M; Palomino J; Peña ML; Trujillo JP; Martín-Vila A; Stolfo D; Molina P; Lara-Pezzi E; Calvo-Iglesias FE; Nof E; Calò L; Barriales-Villa R; Gimeno-Blanes JR; Arad M; García-Pavía P; Monserrat L
J Am Coll Cardiol; 2016 Dec; 68(22):2440-2451. PubMed ID: 27908349
[TBL] [Abstract][Full Text] [Related]
4. Variable clinical expression of a novel FLNC truncating variant in a large family.
Tomer O; Horowitz-Cederboim S; Rivkin D; Meiner V; Gollob MH; Zwas DR; Durst R; Shauer A
Int J Cardiol; 2024 Apr; 401():131849. PubMed ID: 38360096
[TBL] [Abstract][Full Text] [Related]
5. FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations.
Ader F; De Groote P; Réant P; Rooryck-Thambo C; Dupin-Deguine D; Rambaud C; Khraiche D; Perret C; Pruny JF; Mathieu-Dramard M; Gérard M; Troadec Y; Gouya L; Jeunemaitre X; Van Maldergem L; Hagège A; Villard E; Charron P; Richard P
Clin Genet; 2019 Oct; 96(4):317-329. PubMed ID: 31245841
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic variability of filamin C-related cardiomyopathy: Insights from a novel Dutch founder variant.
Schoonvelde SAC; Ruijmbeek CWB; Hirsch A; van Slegtenhorst MA; Wessels MW; von der Thüsen JH; Baas AF; Stroeks SLVM; Verdonschot JAJ; van der Zwaag PA; Verhagen JMA; Michels M
Heart Rhythm; 2023 Nov; 20(11):1512-1521. PubMed ID: 37562486
[TBL] [Abstract][Full Text] [Related]
7. Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy.
Cipriani A; Bauce B; De Lazzari M; Rigato I; Bariani R; Meneghin S; Pilichou K; Motta R; Aliberti C; Thiene G; McKenna WJ; Zorzi A; Iliceto S; Basso C; Perazzolo Marra M; Corrado D
J Am Heart Assoc; 2020 Mar; 9(5):e014628. PubMed ID: 32114891
[TBL] [Abstract][Full Text] [Related]
8. Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell-Cell Adhesion Structures.
Begay RL; Graw SL; Sinagra G; Asimaki A; Rowland TJ; Slavov DB; Gowan K; Jones KL; Brun F; Merlo M; Miani D; Sweet M; Devaraj K; Wartchow EP; Gigli M; Puggia I; Salcedo EE; Garrity DM; Ambardekar AV; Buttrick P; Reece TB; Bristow MR; Saffitz JE; Mestroni L; Taylor MRG
JACC Clin Electrophysiol; 2018 Apr; 4(4):504-514. PubMed ID: 30067491
[TBL] [Abstract][Full Text] [Related]
9. FLNC and MYLK2 Gene Mutations in a Chinese Family with Different Phenotypes of Cardiomyopathy.
Qin X; Li P; Qu HQ; Liu Y; Xia Y; Chen S; Yang Y; Huang S; Wen P; Zhou X; Li X; Wang Y; Tian L; Hakonarson H; Wu Y; Zhuang J
Int Heart J; 2021 Jan; 62(1):127-134. PubMed ID: 33455984
[TBL] [Abstract][Full Text] [Related]
10. Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study.
Augusto JB; Eiros R; Nakou E; Moura-Ferreira S; Treibel TA; Captur G; Akhtar MM; Protonotarios A; Gossios TD; Savvatis K; Syrris P; Mohiddin S; Moon JC; Elliott PM; Lopes LR
Eur Heart J Cardiovasc Imaging; 2020 Mar; 21(3):326-336. PubMed ID: 31317183
[TBL] [Abstract][Full Text] [Related]
11. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
[TBL] [Abstract][Full Text] [Related]
12. Tools to differentiate between Filamin C and Titin truncating variant carriers: value of MRI.
Jacobs J; Van Aelst L; Breckpot J; Corveleyn A; Kuiperi C; Dupont M; Heggermont W; De Vadder K; Willems R; Van Cleemput J; Bogaert JG; Robyns T
Eur J Hum Genet; 2023 Nov; 31(11):1323-1332. PubMed ID: 37032351
[TBL] [Abstract][Full Text] [Related]
13. Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies.
Castrichini M; De Luca A; De Angelis G; Neves R; Paldino A; Dal Ferro M; Barbati G; Medo K; Barison A; Grigoratos C; Gigli M; Stolfo D; Brun F; Groves DW; Quaife R; Eldemire R; Graw S; Addison J; Todiere G; Gueli IA; Botto N; Emdin M; Aquaro GD; Garmany R; Pereira NL; Taylor MRG; Ackerman MJ; Sinagra G; Mestroni L; Giudicessi JR; Merlo M
J Am Coll Cardiol; 2024 May; 83(19):1841-1851. PubMed ID: 38719365
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants.
Gigli M; Stolfo D; Graw SL; Merlo M; Gregorio C; Nee Chen S; Dal Ferro M; PaldinoMD A; De Angelis G; Brun F; Jirikowic J; Salcedo EE; Turja S; Fatkin D; Johnson R; van Tintelen JP; Te Riele ASJM; Wilde AAM; Lakdawala NK; Picard K; Miani D; Muser D; Maria Severini G; Calkins H; James CA; Murray B; Tichnell C; Parikh VN; Ashley EA; Reuter C; Song J; Judge DP; McKenna WJ; Taylor MRG; Sinagra G; Mestroni L
Circulation; 2021 Nov; 144(20):1600-1611. PubMed ID: 34587765
[TBL] [Abstract][Full Text] [Related]
15. Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype-phenotype correlation study.
Segura-Rodríguez D; Bermúdez-Jiménez FJ; Carriel V; López-Fernández S; González-Molina M; Oyonarte Ramírez JM; Fernández-Navarro L; García-Roa MD; Cabrerizo EM; Durand-Herrera D; Alaminos M; Campos A; Macías R; Álvarez M; Tercedor L; Jiménez-Jáimez J
Eur Heart J Cardiovasc Imaging; 2020 Apr; 21(4):378-386. PubMed ID: 31702781
[TBL] [Abstract][Full Text] [Related]
16.
Brun F; Gigli M; Graw SL; Judge DP; Merlo M; Murray B; Calkins H; Sinagra G; Taylor MR; Mestroni L; James CA
J Med Genet; 2020 Apr; 57(4):254-257. PubMed ID: 31924696
[TBL] [Abstract][Full Text] [Related]
17. A mutation update for the FLNC gene in myopathies and cardiomyopathies.
Verdonschot JAJ; Vanhoutte EK; Claes GRF; Helderman-van den Enden ATJM; Hoeijmakers JGJ; Hellebrekers DMEI; de Haan A; Christiaans I; Lekanne Deprez RH; Boen HM; van Craenenbroeck EM; Loeys BL; Hoedemaekers YM; Marcelis C; Kempers M; Brusse E; van Waning JI; Baas AF; Dooijes D; Asselbergs FW; Barge-Schaapveld DQCM; Koopman P; van den Wijngaard A; Heymans SRB; Krapels IPC; Brunner HG
Hum Mutat; 2020 Jun; 41(6):1091-1111. PubMed ID: 32112656
[TBL] [Abstract][Full Text] [Related]
18. Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging.
Te Rijdt WP; Ten Sande JN; Gorter TM; van der Zwaag PA; van Rijsingen IA; Boekholdt SM; van Tintelen JP; van Haelst PL; Planken RN; de Boer RA; Suurmeijer AJH; van Veldhuisen DJ; Wilde AAM; Willems TP; van Dessel PFHM; van den Berg MP
Eur Heart J Cardiovasc Imaging; 2019 Jan; 20(1):92-100. PubMed ID: 29635323
[TBL] [Abstract][Full Text] [Related]
19. RNA sequencing-based transcriptome profiling of cardiac tissue implicates novel putative disease mechanisms in FLNC-associated arrhythmogenic cardiomyopathy.
Hall CL; Gurha P; Sabater-Molina M; Asimaki A; Futema M; Lovering RC; Suárez MP; Aguilera B; Molina P; Zorio E; Coarfa C; Robertson MJ; Cheedipudi SM; Ng KE; Delaney P; Hernández JP; Pastor F; Gimeno JR; McKenna WJ; Marian AJ; Syrris P
Int J Cardiol; 2020 Mar; 302():124-130. PubMed ID: 31843279
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular involvement assessed by LGE-CMR in predicting the risk of adverse outcomes of arrhythmogenic cardiomyopathy with ICDs.
Zhang N; Song Y; Hua W; Hu Y; Chen L; Cai M; Niu H; Cai C; Gu M; Zhao S; Zhang S
Int J Cardiol; 2021 Aug; 337():79-85. PubMed ID: 33839174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
